Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdFIrst phase III trial of intraoperative BT524 in major spinal or abdominal surgery
2017-001163-20Phase 3Completed
- Sponsor
- Biotest AG
- Start
- Apr 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Fibrinogen human in hypofibrinogenemia and Bleeding (2 arms), sponsored by Biotest AG. Primary endpoint: Intra-operative blood loss. Started Apr 2017; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
hypofibrinogenemiaBleeding
Beyond the preview
Go deeper on 2017-001163-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001163-20.